/Home

Find the right investors for your startup

A free, open database of 27,281 venture funds and 217,482 investors — searchable by stage, sector, and location. No login required.

Tracking the funds you know

Deal radar

Fresh SEC Form D filings our pipeline links to tracked companies and investors — often days before the news breaks. A Form D is the short notice a company or fund must file within 15 days of taking its first money, so it names the amount, the count of investors, and the officers and directors behind the raise.

  • Oct 2, 2026 · San Carlos, CA · Biotechnology

    $15.7Mraised of $45.1M

    Altay Therapeutics develops small molecule inhibitors targeting transcription factors to treat serious diseases including facioscapulohumeral muscular dystrophy and cancer. The company's pipeline includes oral drug candidates designed as first- or best-in-class therapeutics for oncology and inflammatory conditions.

    Altay Therapeutics told the SEC it has taken in $15.7M of a $45.1M round from 19 investors, with the first money in on Sep 17, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 3 of the 7 people it names are partners at firms we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

    Founders
  • Confirm Global

    Oct 2, 2026 · Littleton, CO · Other

    $425Koffered

    Confirm Global told the SEC it opened a $425K round. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement.

    On the filing
    Paul Ford
  • Oct 2, 2026 · Houston, TX · Other Energy

    $5.1Mraised

    TMNTec, Inc. told the SEC it has taken in $5.1M from 11 investors, with the first money in on Sep 18, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 1 of the 4 people it names is a partner at a firm we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

  • General Intuition Holding

    Oct 2, 2026 · Naarden, P7 · Other Technology

    $175.2Mraised of $220.5M

    General Intuition Holding told the SEC it has taken in $175.2M of a $220.5M round from 32 investors, with the first money in on Sep 18, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 3 of the 17 people it names are partners at firms we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

  • Oct 2, 2026 · Basking Ridge, NJ · Biotechnology

    $351.9Mraised

    Lisata Therapeutics is a clinical-stage biopharmaceutical company developing certepetide, an investigational peptide designed to enhance the delivery and efficacy of anti-cancer drugs to solid tumors by activating a tumor-specific transport mechanism, while also modifying the tumor microenvironment to improve response to immunotherapy. The company is pursuing clinical development of certepetide in combination with chemotherapy and immunotherapy across multiple solid tumor types including pancreatic cancer, cholangiocarcinoma, and glioblastoma.

    Caladrius Biosciences told the SEC it has taken in $351.9M from 20 investors, with the first money in on Sep 17, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement.

  • Oct 2, 2026 · Boulder, CO · Other Technology

    $13Mraised

    Suite Studios offers a file streaming product that lets teams access and work with cloud-stored files in real time without pre-downloading or syncing, with cloud storage that mounts like a local SSD. It targets creative teams and studios collaborating on media assets across distributed locations.

    Suite Studios told the SEC it has taken in $13M from 10 investors, with the first money in on Sep 17, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 2 of the 7 people it names are partners at firms we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

    Founders
    Craig HeringJay MaxwellMichael HeringJames D. Maxwell
  • Oct 2, 2026 · Menlo Park, CA

    This page announces that GGV Capital split into two separate firms in March 2024: Granite Asia (Singapore, covering APAC) and Notable Capital (US, based in Silicon Valley with offices in San Francisco and New York, investing in the US, Israel, Europe, and Latin America).

    Notable Capital X L.P. is a pooled investment vehicle — a fund raising from its own backers, not a startup round. It reported a new raise. All 3 people it names are partners at firms we track.

  • Anti Fund II, LPfund vehicle

    Oct 1, 2026 · Miami, FL

    $400Moffered

    Anti Fund is an early-stage-to-growth venture firm that backs technical, anti-consensus founders and pairs technical judgment with distribution and attention to help companies define new market categories.

    Anti Fund II, LP is a pooled investment vehicle — a fund raising from its own backers, not a startup round. It is raising $400M. All 2 people it names are partners at firms we track.

    On the filing
  • Oct 1, 2026 · New York, NY · Other Banking and Financial Services

    $42Mraised

    Kashable provides employer-sponsored financial wellness benefits, offering low-cost loans that integrate with HRIS and payroll systems and are repaid automatically through payroll, along with financial education. Its loans are offered to employees as a voluntary benefit through their employers.

    Kashable told the SEC it has taken in $42M from 9 investors, with the first money in on Jan 30, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 2 of the 5 people it names are partners at firms we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

  • Oct 1, 2026 · Palo Alto, CA · Other Technology

    $145Mraised of $195M

    Cspeed told the SEC it has taken in $145M of a $195M round from 37 investors, with the first money in on Jul 17, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 1 of the 5 people it names is a partner at a firm we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

    On the filing
  • Atlas Growth Select Fund, L.P. - Series 1fund vehicleRule 506(c)

    Oct 1, 2026 · San Francisco, CA

    $10.3Mraised

    Atlas Growth Select Fund, L.P. - Series 1 is a pooled investment vehicle — a fund raising from its own backers, not a startup round. It has closed $10.3M from 6 investors.

  • Oct 1, 2026 · New York, NY · Other Health Care

    $50Mraised

    Click Therapeutics develops, validates, and commercializes software-based prescription medical treatments, including software-enhanced drug products that combine digital therapeutics with pharmacotherapy. It targets diseases through a platform-based approach applying neuroscience and neuromodulatory mechanisms for patients with unmet medical needs.

    Click Therapeutics told the SEC it has taken in $50M from 1 investors, with the first money in on Apr 7, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 4 of the 12 people it names are partners at firms we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

  • OV Surge SPV 2026, LLCfund vehicle

    Oct 1, 2026 · Chicago, IL

    $1.1Moffered

    OV Surge SPV 2026, LLC is a pooled investment vehicle — a fund raising from its own backers, not a startup round. It is raising $1.1M. 2 of the 3 people it names are partners at firms we track.

  • Sep 30, 2026 · Atlanta, GA · Other Health Care

    $11Mraised of $11.7M

    Huxley develops SANSA, a cellular-enabled chest-worn monitor and diagnostic service that detects obstructive and central sleep apnea and records ECG from a single at-home device. It serves sleep labs, cardiology clinics, and primary care providers with AI-assisted reporting and managed testing logistics.

    Huxley Medical told the SEC it has taken in $11M of a $11.7M round from 40 investors, with the first money in on Sep 16, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 1 of the 7 people it names is a partner at a firm we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

From public SEC filings; automated matching — filings are facts, interpretations are estimates. See how we read these: the Airtable × Bending Spoons waterfall → The DroneDeploy × Procore waterfall → Every recent raise →

Popular investor lists

Building on the data?

The whole graph as a daily-updated JSON API: firms, companies, rounds, investor→company edges with evidence, funds and SEC filings. Free trial key, no card.

Data API →